176 related articles for article (PubMed ID: 29622909)
1. Anemia among HIV Infected Individuals Taking ART with and without Zidovudine at Addis Ababa, Ethiopia.
Tamir Z; Alemu J; Tsegaye A
Ethiop J Health Sci; 2018 Jan; 28(1):73-82. PubMed ID: 29622909
[TBL] [Abstract][Full Text] [Related]
2. Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS.
Renner LA; Dicko F; Kouéta F; Malateste K; Gueye RD; Aka E; Eboua TK; Azondékon A; Okomo U; Touré P; Ekouévi D; Leroy V;
J Int AIDS Soc; 2013 Sep; 16(1):18024. PubMed ID: 24047928
[TBL] [Abstract][Full Text] [Related]
3. High incidence of zidovudine induced anaemia in HIV infected patients in eastern India.
Agarwal D; Chakravarty J; Chaube L; Rai M; Agrawal NR; Sundar S
Indian J Med Res; 2010 Oct; 132():386-9. PubMed ID: 20966515
[TBL] [Abstract][Full Text] [Related]
4. Development of Severe Anemia and Changes in Hemoglobin in a Cohort of HIV-Infected Ugandan Adults Receiving Zidovudine-, Stavudine-, and Tenofovir-Containing Antiretroviral Regimens.
Parkes-Ratanshi R; Katende D; Levin J; Wakeham K; Heiner G; Kamali A; Lalloo DG
J Int Assoc Provid AIDS Care; 2015; 14(5):455-62. PubMed ID: 25425638
[TBL] [Abstract][Full Text] [Related]
5. Zidovudine impairs immunological recovery on first-line antiretroviral therapy: collaborative analysis of cohort studies in southern Africa.
Wandeler G; Gsponer T; Mulenga L; Garone D; Wood R; Maskew M; Prozesky H; Hoffmann C; Ehmer J; Dickinson D; Davies MA; Egger M; Keiser O;
AIDS; 2013 Sep; 27(14):2225-32. PubMed ID: 23660577
[TBL] [Abstract][Full Text] [Related]
6. HIV-associated anaemia before and after initiation of antiretroviral therapy at Art Centre of Minilik II Hospital, Addis Ababa, Ethiopia.
Adane A; Desta K; Bezabih A; Gashaye A; Kassa D
Ethiop Med J; 2012 Jan; 50(1):13-21. PubMed ID: 22519158
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Severe Neutropenia in HIV-Infected People Starting Antiretroviral Therapy in West Africa.
Leroi C; Balestre E; Messou E; Minga A; Sawadogo A; Drabo J; Maiga M; Zannou M; Seydi M; Dabis F; Jaquet A;
PLoS One; 2017; 12(1):e0170753. PubMed ID: 28122041
[TBL] [Abstract][Full Text] [Related]
8. Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts.
Ouattara E; Danel C; Moh R; Gabillard D; Peytavin G; Konan R; Carrou JL; Bohoussou F; Eholie SP; Anglaret X
J Int AIDS Soc; 2013 Apr; 16(1):18059. PubMed ID: 23639243
[TBL] [Abstract][Full Text] [Related]
9. Magnitude and associated factors of anemia among AZT based HAART experienced adult HIV patients at University of Gondar Comprehensive Specialized Referral Hospital, Northwest, Ethiopia, 2019: a retrospective cohort study.
Getaneh Z; Wale W; Chanie B; Temesgen E; Abebe M; Walie M; Lemma M
BMC Infect Dis; 2021 Sep; 21(1):1016. PubMed ID: 34583644
[TBL] [Abstract][Full Text] [Related]
10. Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial.
Bussmann H; Wester CW; Thomas A; Novitsky V; Okezie R; Muzenda T; Gaolathe T; Ndwapi N; Mawoko N; Widenfelt E; Moyo S; Musonda R; Mine M; Makhema J; Moffat H; Essex M; Degruttola V; Marlink RG
J Acquir Immune Defic Syndr; 2009 May; 51(1):37-46. PubMed ID: 19282782
[TBL] [Abstract][Full Text] [Related]
11. Safety of zidovudine dose reduction in treatment-naïve HIV infected patients. A randomized controlled study (MiniZID).
Rougemont M; Nchotu Ngang P; Stoll B; Delhumeau C; Hill A; Ciaffi L; Bonnet F; Menga G; Fampou JC; Calmy A
HIV Med; 2016 Mar; 17(3):206-15. PubMed ID: 26354678
[TBL] [Abstract][Full Text] [Related]
12. Magnitude and correlates of moderate to severe anemia among adult HIV patients receiving first line HAART in Northwestern Tanzania: a cross sectional clinic based study.
Gunda DW; Kilonzo SB; Mpondo BC
Pan Afr Med J; 2016; 23():26. PubMed ID: 27200131
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of severe infant anemia after exposure to maternal HAART, Botswana.
Dryden-Peterson S; Shapiro RL; Hughes MD; Powis K; Ogwu A; Moffat C; Moyo S; Makhema J; Essex M; Lockman S
J Acquir Immune Defic Syndr; 2011 Apr; 56(5):428-36. PubMed ID: 21266910
[TBL] [Abstract][Full Text] [Related]
14. Incidence of anaemia among HIV-infected patients treated with highly active antiretroviral therapy.
Curkendall SM; Richardson JT; Emons MF; Fisher AE; Everhard F
HIV Med; 2007 Nov; 8(8):483-90. PubMed ID: 17944680
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of anaemia in HIV-infected children at the University of Abuja Teaching Hospital, Gwagwalada.
Okechukwu AA; Gambo D; Okechukwu IO
Niger J Med; 2010; 19(1):50-7. PubMed ID: 20232757
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of incidence of zidovudine induced anemia in Indian human immunodeficiency virus positive patients in comparison with stavudine based highly active antiretroviral therapy.
Rajesh R; Vidyasagar S; Varma DM; Mohiuddin S; Noorunnisa
Int J Risk Saf Med; 2011; 23(3):171-80. PubMed ID: 22020397
[TBL] [Abstract][Full Text] [Related]
17. Intestinal parasitosis in relation to CD4+T cells levels and anemia among HAART initiated and HAART naive pediatric HIV patients in a Model ART center in Addis Ababa, Ethiopia.
Mengist HM; Taye B; Tsegaye A
PLoS One; 2015; 10(2):e0117715. PubMed ID: 25658626
[TBL] [Abstract][Full Text] [Related]
18. Induction with abacavir/lamivudine/zidovudine plus efavirenz for 48 weeks followed by 48-week maintenance with abacavir/lamivudine/zidovudine alone in antiretroviral-naive HIV-1-infected patients.
Markowitz M; Hill-Zabala C; Lang J; DeJesus E; Liao Q; Lanier ER; Davis EA; Shaefer M;
J Acquir Immune Defic Syndr; 2005 Jul; 39(3):257-64. PubMed ID: 15980684
[TBL] [Abstract][Full Text] [Related]
19. Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons.
Alvarez D; Dieterich DT; Brau N; Moorehead L; Ball L; Sulkowski MS
J Viral Hepat; 2006 Oct; 13(10):683-9. PubMed ID: 16970600
[TBL] [Abstract][Full Text] [Related]
20. Association between in utero zidovudine exposure and nondefect adverse birth outcomes: analysis of prospectively collected data from the Antiretroviral Pregnancy Registry.
Vannappagari V; Koram N; Albano J; Tilson H; Gee C
BJOG; 2016 May; 123(6):910-6. PubMed ID: 26269220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
